Boardroom Alpha
Meeting calendar
FNB · Annual meeting · Wednesday, May 6, 2026

Fnb Corp

10 nominees · 3 ballot items.

Election of 10 directors; advisory approval of 2025 named executive officer compensation (Say-on-Pay); and ratification of Ernst & Young LLP as independent registered public accounting firm for 2026.

Market cap
$6.8B
1Y TSR
+23.5%
Board grade
B-
Record date
Mar 9, 2026
Filing
DEF 14A
Meeting concluded · May 6, 2026

Follow how the vote landed and what changed on Fnb Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Our Board of Directors

    ManagementBoard: FOR

    Elect ten director nominees named in the proxy statement to serve until the 2027 Annual Meeting.

  2. 2

    Advisory Resolution on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Adopt a non-binding advisory resolution to approve the 2025 compensation of the named executive officers as disclosed in the proxy statement.

  3. 3

    Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for 2026

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of Ernst & Young LLP as FNB’s independent registered public accounting firm for 2026.

Director elections

Nominees on the ballot10

Independent
Tenure on this board
12.9 yrs
Also a director at
Koppers Holdings Inc (KOP)Coherent Corp (COHR)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.7.4%26,435,965$442M
2VANGUARD PORTFOLIO MANAGEMENT LLC5.5%19,676,421$329M
3DIMENSIONAL FUND ADVISORS LP5.4%19,162,241$320M
4FULLER THALER ASSET MANAGEMENT, INC.5.0%17,867,600$299M
5VANGUARD CAPITAL MANAGEMENT LLC4.5%16,018,694$268M
6STATE STREET CORP4.3%15,415,495$258M
7FMR LLC4.1%14,500,732$242M
8BlackRock, Inc.3.3%11,835,963$198M
9FIRST TRUST ADVISORS LP3.1%10,978,635$184M
10TWO SIGMA INVESTMENTS, LP2.1%7,470,738$125M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Fnb Corp 2026 annual meeting?
Fnb Corp (FNB) holds its 2026 annual shareholder meeting on Wednesday, May 6, 2026.
What is the record date for the Fnb Corp 2026 meeting?
The record date for the Fnb Corp 2026 meeting is Monday, March 9, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Fnb Corp's 2026 meeting?
The board is presenting 10 director nominees at the Fnb Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Fnb Corp 2026 meeting?
Shareholders will vote on 3 proposals at the Fnb Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer